Samuel D. Waksal
id:
samuel-d-waksal-206-12747782
title:
Samuel D. Waksal
text:
Samuel D. Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals, which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the cancer drug Erbitux (cetuximab). During the course of its review process with the Food and Drug Administration (FDA) Waksal became involved in an insider trading scandal revolving around improper communications w
brand slug:
wiki
category slug:
encyclopedia
description:
American immunologist, businessman and convicted insider trader
original url:
https://en.wikipedia.org/wiki/Samuel_D._Waksal
date created:
2002-08-10T09:36:15Z
date modified:
2024-09-10T22:21:38Z
main entity:
{"identifier":"Q7411220","url":"https://www.wikidata.org/entity/Q7411220"}
image:
fields total:
13
integrity:
15